Venus Medtech (Hangzhou) Inc. (2500.HK) HKSE

2.37

+0.03(+1.28%)

Updated at December 05 04:09PM

Currency In HKD

Valuation

Market Cap995.28M
Enterprise Value1.07B
P/E Ratio-1.44
PEG Ratio-0.15
Price/Sales Ratio2.17
Price/Book Ratio0.45
Enterprise/Revenue2.67
Enterprise/EBITDA-1.99

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-1.5
Operating Margin-0.65

Management Effectiveness

Return On Assets-0.21
Return On Equity-0.3

Income Statement

Revenue470.83M
Revenue/Share0.98
Gross Profit367.75M
EBITDA-612.96M
Net Income-714.31M
Diluted EPS-1.63

Balance Sheet

Total Cash293.31M
Total Cash/Share0.67
Total Debt493.59M
Total Debt/Equity0.24
Current Ratio1.82
Book Value Per Share4.72

Price History

52-Week Change-3.72
52-Week High5.62
52-Week Low1.59
Moving Average 50 Days2.74
Moving Average 200 Days3.15

Statistics

Average Volume2.28M
Shares Outstanding437.77M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A